The Role of Remifentanil in Obstetric Analgesia: A Review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F16%3A00089368" target="_blank" >RIV/00216224:14110/16:00089368 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

The Role of Remifentanil in Obstetric Analgesia: A Review

Popis výsledku v původním jazyce

Standard for labour analgesia due to its efficacy. In cases of contraindication, systemic remifentanil is possible as alternative. The first demonstration of the safety of remifentanil in obstetric analgesia was in 1996 and since then, its safety for mother and newborn has been repeatedly confirmed. The aim of this review is to provide a summary of current information on the efficacy and safety of remifentanil during labour. Methods: Search of the US National Library of Medicine, National Institutes of Health (www.pubmed.gov), SCOPUS database (www.scopus.com) and Web of Science database (www.webofknowledge.com) using the key words “labour” and “remifentanil.” Results: Forty four identified articles were included into review. We described possible modes of application, dosage and side-effects for mother, fetus or newborn in the review.

Název v anglickém jazyce

The Role of Remifentanil in Obstetric Analgesia: A Review

Popis výsledku anglicky

Standard for labour analgesia due to its efficacy. In cases of contraindication, systemic remifentanil is possible as alternative. The first demonstration of the safety of remifentanil in obstetric analgesia was in 1996 and since then, its safety for mother and newborn has been repeatedly confirmed. The aim of this review is to provide a summary of current information on the efficacy and safety of remifentanil during labour. Methods: Search of the US National Library of Medicine, National Institutes of Health (www.pubmed.gov), SCOPUS database (www.scopus.com) and Web of Science database (www.webofknowledge.com) using the key words “labour” and “remifentanil.” Results: Forty four identified articles were included into review. We described possible modes of application, dosage and side-effects for mother, fetus or newborn in the review.

Druh

C - Kapitola v odborné knize

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Advances in Medicine and Biology

ISBN

9781634841863

Počet stran výsledku

16

Strana od-do

1-16

Počet stran knihy

202

Název nakladatele

Nova Science Publishers

Místo vydání

New York

Kód UT WoS kapitoly

—